Stay updated on CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.

Latest updates to the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, signaling an update to the page version and superseding the previous revision (v3.6.2).SummaryDifference0.1%

- Check11 days agoChange DetectedThe history now shows a new revision entry (v3.6.2) and removes the previous revision (v3.6.0), indicating an update to the page's release version. This change reflects an administrative update to the page rendering rather than content changes.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page adds quick-access links for eligibility checks and contacting the study team. The revision log now shows a new 3.6.0 release replacing 3.5.5.SummaryDifference0.4%

- Check32 days agoChange DetectedThe page footer's revision was updated from v3.5.4 to v3.5.5, indicating a new build release.SummaryDifference0.1%

- Check39 days agoChange DetectedThe history shows a substantial expansion of the study record with new sections (IPDSharing, Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Oversight, Study Status, Study Identification) added during 2026 updates, alongside a minor capitalization tweak in the title.SummaryDifference1%

- Check53 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, while the previous v3.5.3 entry was removed. This reflects a minor update to the page’s revision trail.SummaryDifference0.1%

Stay in the know with updates to CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.